Related Articles
Diagnostic value of VDBP and miR‑155‑5p in diabetic nephropathy and the correlation with urinary microalbumin
High mobility group box 1 and kidney diseases (Review)
Elevated urinary level of vitamin D‑binding protein as a novel biomarker for diabetic nephropathy
Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review)
Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review)